You're Invited: Hormonal IUS Event

2 June, 2020

You're Invited: Hormonal IUS Event


New Insights and Steps Toward Scale

Wednesday, June 24, 9:00am-11:00 EDT

Thursday, June 25, 9:00am-11:00 EDT

Register Now

How can we continue to expand contraceptive method choice during the COVID-19 crisis?

Expanding contraceptive choice increases individuals’ ability to freely choose the family planning methods that best meet their reproductive desires and needs. Join us for a two-part virtual technical consultation to identify opportunities to expand access to the levonorgestrel intrauterine system (IUS) - also known as the hormonal IUS as part of a a broader method mix.

The hormonal IUS has important advantages:

- One of the most effective forms of long-acting reversible contraception available

- Can have fewer side effects than some other hormonal methods

- Offers non-contraceptive benefits such as reducing menstrual cramps and blood loss

- Potentially alleviates anemia in some populations

Despite these advantages, the hormonal IUS is not widely available in low- and middle-income countries. How can we overcome supply- and demand-side barriers to access?

Join the Method Choice Community of Practice, led by the Evidence to Action (E2A) Project, and the Hormonal IUS Access Group for this online event. Participants will:

Review key features of the hormonal IUS and current product availability in LMICs

Get updates from the Hormonal IUS Access Group

Increase understanding of current global evidence

Receive updates from Kenya, Madagascar, Nigeria, Zambia, and elsewhere

Share service delivery tools and identify gaps

Review and discuss updates to the global learning agenda

Discuss how to move forward - including during the COVID-19 pandemic


HIFA profile: Ados May is a Senior Technical Advisor at the IBP Initiative in the United States of America.